Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

A look at the specialty landscape and how Prime delivers value to employers

What works and what doesn’t

Magellan Rx's businesses includes a 1.7-million member PBM. The deal is struck amid a long-time trend toward consolidation in the pharmacy benefit management industry

cover image for Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights Prime Therapeutics /trending-topics-drug-approvals-june-2025-1 Prime Therapeutics’...

Formulary Watch: The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization management requirements and finding financial assistance.

Event will feature David Lassen, chief clinical officer

Join Prime/Magellan Rx CEO Mostafa Kamal and Capital Rx CEO AJ Loiacono for their presentation, “Transformation within the pharmacy benefits ecosystem.”

Prime experts will dive into the latest trends in spend, disease categories and cost management strategies for payers.